Welcome to our dedicated page for Canton Strategic Holdings SEC filings (Ticker: CNTN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Canton Strategic Holdings, Inc. filings document material events, financial results, capital-raising arrangements and governance developments tied to its Canton Network strategy. Recent Form 8-K disclosures include annual operating results, Canton Coin and Super Validator strategy details, Canton Foundation governance updates and the company's continuing clinical-stage biotechnology operations.
The company's filings also describe common stock sales agreements, at-the-market offering mechanics and the use of a Form S-3 registration statement for potential common stock issuance. These records provide formal disclosure on the company's capital structure, material agreements, digital asset treasury strategy and public-company governance matters.
Canton Strategic Holdings reported its first operating revenue for the quarter ended June 30, 2026 as it pivots to blockchain-based activities on the Canton Network. Total revenue was $1.50 million, including $1.30 million from its locking-as-a-service offering and $191,226 of network validation revenue from Super Validator operations, establishing a recurring operating base tied to Canton Coin activity.
Results remained deeply loss-making. Net loss from continuing operations for the quarter was $17.95 million, and total net loss was $19.25 million, largely driven by an unrealized loss on digital asset holdings of $23.74 million. For the first half of 2026, net loss reached $66.60 million, including $38.75 million of unrealized digital asset losses and $32.33 million of stock-based compensation, much of it related to a November 2025 PIPE. On a non-GAAP basis, Adjusted EBITDA for the quarter was a loss of $0.82 million and Adjusted Operating Expenses were $2.63 million, yielding an Adjusted Operating Expenses coverage ratio of 56.9%.
The balance sheet is dominated by digital assets of $523.35 million and cash and cash equivalents of $37.24 million as of June 30, 2026, funded by $91.25 million of net cash from equity financing in the first half. The company also detailed a Super Validator weight program that could increase active network weight from 0.5 to 15 by early 2028, contingent on meeting Canton Improvement Proposal milestones and maintaining required Canton Coin balances.
Canton Strategic Holdings, Inc. is transitioning from a clinical-stage biotechnology company to a Canton Coin (CC)-focused digital asset treasury business. The Gravitas biotech subsidiary is classified as discontinued operations and held for sale at June 30, 2026, with a related six‑month loss of $2.9M.
Continuing operations generated $1.5M of revenue in the first half of 2026, all from network validation and locking-as-a-service on the Canton Network, but reported a large net loss of $66.6M, driven by an $38.7M unrealized loss on digital asset holdings and $32.3M of stock-based compensation, mainly advisor warrants. The company holds 3.71B CC with fair value of $523.4M and cash of $37.2M against total liabilities of $109.7M, after raising $91.2M net from equity offerings in the first half of 2026. CC options are used as part of the treasury strategy, with a small derivative liability of $0.1M recorded at fair value.
Canton Strategic Holdings, Inc. has completed the sale of all membership interests in its clinical-stage biotech subsidiary, Gravitas Life Sciences, LLC, to Gravitas Collective Corp., an entity affiliated with former directors. Consideration consists of an unsecured $3,500,000 Gravitas Note bearing 15% per-annum, payable-in-kind interest, maturing on July 17, 2029, plus potential development milestone payments. A special committee of independent, non-interested directors reviewed and unanimously approved the transaction, which the full board also approved. Gravitas’ bispecific antibody development assets were retained through subsidiary Tharimmune SPV1.
Pro forma financial statements for March 31, 2026 and for 2025 present Canton Strategic without Gravitas. On a pro forma basis, total assets at March 31, 2026 are $586,523,091, including $541,569,363 of digital assets and the new $3,500,000 note receivable, and stockholders’ equity is $472,023,616. Pro forma net loss is $45,544,391 for the quarter ended March 31, 2026 and $25,816,965 for the year ended December 31, 2025. The company states that this divestiture supports its focus on digitizing financial markets through the Canton Network.
Canton Strategic Holdings, Inc. held its 2026 annual meeting of stockholders on July 13, 2026. As of the June 16, 2026 record date, 77,122,584 shares of common stock were outstanding, and 25,792,741 shares were represented in person or by proxy, constituting a quorum. Stockholders elected seven directors to serve until the 2027 annual meeting, with each nominee receiving at least 25,490,487 votes for, small numbers of abstentions, and no broker non-votes reported.
Stockholders also ratified the appointment of Rosenberg Rich Baker Berman P.A. as independent registered public accounting firm for the fiscal year ending December 31, 2026, by 25,780,986 votes for, 3,980 against and 7,775 abstaining. At a July 15, 2026 special board meeting, the board appointed members and chairs for its Audit, Compensation, and Nominating and Governance Committees, with Sean Galvin, William Wiley, and Jill E. Sommers serving as the respective chairs.
Canton Strategic Holdings, Inc. director Rishi Nangalia filed an initial Form 3 as a reporting person for CNTN. The filing lists no reportable transactions and no derivative securities, indicating that, as of this filing, no equity or option holdings are disclosed for this insider.
Canton Strategic Holdings, Inc. reported the initial beneficial ownership position of director Pamela L. Carter. She is identified as a director and not a ten percent owner, and no equity or derivative securities or insider transactions are reported for her at the time of this statement.
Canton Strategic Holdings, Inc. reports that Sean Galvin has filed an initial Form 3 as a reporting person. He is identified as a director, not an officer or a ten percent owner, and the form shows no reported transactions or currently reported holdings or derivatives.
Canton Strategic Holdings, Inc. Schedule 13G/A reports that ARK Investment Management LLC and Catherine D. Wood beneficially own 3,657,548 shares of Common Stock, representing 4.74% of the class as of 06/30/2026.
The filing states ARK has sole voting and dispositive power over 3,657,548 shares while Catherine D. Wood has shared voting and dispositive power over 3,657,548 shares. The amendment is signed on 07/08/2026.
Canton Strategic Holdings, Inc. is holding its 2026 annual stockholders meeting as a fully virtual event on July 13, 2026 at 2:00 p.m. Eastern Time. Stockholders of record as of June 16, 2026, when 77,122,584 common shares were outstanding, are entitled to vote.
Investors are being asked to elect seven directors and to ratify Rosenberg Rich Baker Berman P.A. as independent auditor for the year ending December 31, 2026. Six of the seven director nominees are classified as independent under Nasdaq rules, and all key board committees are composed of independent directors.
The proxy details an insider trading policy that bans short sales, hedging and pledging without pre-approval, and outlines executive pay. For 2025, former interim CEO Sireesh Appajosyula received total compensation of $2,881,544, while current CEO Mark Wendland received $358,333 after his November 2025 appointment. The company maintains multiple equity incentive plans and has significantly expanded share reserves under its 2023 Omnibus Equity Incentive Plan.
Canton Strategic Holdings, Inc. authorized a share repurchase program of up to $50 million of its common stock, approved by the Board of Directors on June 11, 2026. The company may buy shares in open-market or privately negotiated transactions in line with Rule 10b-18.
On June 12, 2026, Canton Strategic entered a Rule 10b-18 Repurchase Agreement with Virtu Americas LLC, which will act as a non-exclusive agent to execute open-market repurchases. Canton Strategic will pay Virtu a $0.02 commission per share repurchased. The timing and total amount of repurchases are discretionary and the program can be modified, suspended, or terminated by the Board.